NUVALENT, INC. Share Price Today: Live Updates & Key Insights
NUVALENT, INC. share price today is $94.77, up -2.36%. The stock opened at $96.91 against the previous close of $97.06, with an intraday high of $97.72 and low of $94.76.
NUVALENT, INC. Share Price Chart
NUVALENT, INC.
NUVALENT, INC. Share Price Performance
NUVALENT, INC. Institutional Holdings
NUVALENT, INC. Market Status
NUVALENT, INC. Fundamentals
Market Cap 7450.53 M
PB Ratio 5.9772
PE Ratio 0.0
Enterprise Value 6089.59 M
Total Assets 1412.71 M
Volume 951776
NUVALENT, INC. Company Financials
About NUVALENT, INC. & investment objective
Company Information Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Its lead product candidates are Zidesamtinib (NVL-520), a novel ROS1-selective inhibitor to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of ROS1 tyrosine kinase inhibitors (TKIs) for patients with ROS proto-oncogene 1 (ROS1)-positive non-small cell lung cancer (NSCLC) which is under the Phase 2 portion of the ARROS-1 Phase 1/2 clinical trial; Neladalkib (NVL-655), a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under the Phase 2 portion of the ALKOVE-1 clinical trial; and NVL-330, a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to treat tumors driven by HER2ex20, brain metastases, and avoiding treatment-limiting adverse events including due to off-target inhibition of wild-type EGFR that is in Phase 1a/1b clinical trial. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Organisation Biotechnology
Employees 228
Industry Biotechnology
CEO Dr. James R. Porter Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
NUVALENT, INC. FAQs
What is the share price of NUVALENT, INC. today?
The current share price of NUVALENT, INC. is $94.77.
Can I buy NUVALENT, INC. shares in India?
Yes, Indian investors can buy NUVALENT, INC. shares by opening an international trading and demat account with Motilal Oswal.
How to buy NUVALENT, INC. shares in India?
You can easily invest in NUVALENT, INC. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy NUVALENT, INC. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of NUVALENT, INC..
Can I buy fractional shares of NUVALENT, INC.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of NUVALENT, INC.?
NUVALENT, INC. has a market cap of $7450.53 M.
In which sector does NUVALENT, INC. belong?
NUVALENT, INC. operates in the Biotechnology sector.
What documents are required to invest in NUVALENT, INC. stocks?
To invest, you typically need:
What is the PE and PB ratio of NUVALENT, INC.?
The PE ratio of NUVALENT, INC. is N/A and the PB ratio is 5.98.